Financial News
Biocryst Pharma Inc (NQ: BCRX )
6.460
-0.110
(-1.67%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 31, 2024
Add to My Watchlist
Historical Prices
Year:
| Date | Open | High | Low | Close | Volume | Change (%) |
|---|---|---|---|---|---|---|
| Apr 30, 2019 | 7.510 | 7.685 | 7.170 | 7.430 | 1,147,971 | -0.08(-1.07%) |
| Apr 29, 2019 | 7.700 | 7.770 | 7.400 | 7.510 | 802,631 | -0.18(-2.34%) |
| Apr 26, 2019 | 7.980 | 8.035 | 7.540 | 7.690 | 968,300 | -0.30(-3.75%) |
| Apr 25, 2019 | 7.970 | 8.110 | 7.790 | 7.990 | 481,116 | +0.00(+0.00%) |
| Apr 24, 2019 | 8.140 | 8.230 | 7.960 | 7.990 | 639,876 | -0.15(-1.84%) |
| Apr 23, 2019 | 8.080 | 8.420 | 7.900 | 8.140 | 821,141 | -0.01(-0.12%) |
| Apr 22, 2019 | 7.940 | 8.170 | 7.745 | 8.150 | 976,252 | +0.23(+2.90%) |
| Apr 18, 2019 | 7.710 | 7.960 | 7.560 | 7.920 | 1,133,000 | +0.23(+2.99%) |
| Apr 17, 2019 | 8.350 | 8.390 | 7.450 | 7.690 | 1,216,058 | -0.65(-7.79%) |
| Apr 16, 2019 | 8.510 | 8.560 | 8.280 | 8.340 | 402,168 | -0.09(-1.07%) |
| Apr 15, 2019 | 8.500 | 8.650 | 8.220 | 8.430 | 471,148 | -0.10(-1.17%) |
| Apr 12, 2019 | 8.850 | 8.890 | 8.430 | 8.530 | 457,200 | -0.23(-2.63%) |
| Apr 11, 2019 | 8.720 | 8.850 | 8.570 | 8.760 | 854,504 | +0.07(+0.81%) |
| Apr 10, 2019 | 8.240 | 8.780 | 8.140 | 8.690 | 1,251,875 | +0.48(+5.85%) |
| Apr 09, 2019 | 8.500 | 8.626 | 8.140 | 8.210 | 1,516,991 | -0.35(-4.09%) |
| Apr 08, 2019 | 9.130 | 9.150 | 8.540 | 8.560 | 1,194,055 | -0.59(-6.45%) |
| Apr 05, 2019 | 8.860 | 9.260 | 8.831 | 9.150 | 2,005,000 | +0.31(+3.51%) |
| Apr 04, 2019 | 8.620 | 8.875 | 8.547 | 8.840 | 1,585,522 | +0.21(+2.43%) |
| Apr 03, 2019 | 8.670 | 8.780 | 8.470 | 8.630 | 1,283,715 | -0.02(-0.23%) |
| Apr 02, 2019 | 8.420 | 8.740 | 8.330 | 8.650 | 898,318 | +0.32(+3.84%) |
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
